Clinical Trial Info

A Study of Baricitinib in Participants With Rheumatoid Arthritis (RA-BRANCH)

Authored by
Staff

This post-marketing Phase 4 study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis (RA).